Peptides DB
Research-centric peptide and protocol reference hub
Study 3 of 8ABS-201 literatureThe Journal of investigative dermatology · Review2026

Artificial intelligence-enabled precision medicine for inflammatory skin diseases.

AI holds promise for advancing the diagnosis and treatment of inflammatory skin diseases, but its clinical integration requires careful validation.

Read at The Journal of investigative dermatologyAdd to compare

Where it sits

this study against the rest of the abs-201 corpus
3
Preclinical
0
Observational
0
Open-label
0
Randomised
5
Reviews · this one

Summary and findings

This review explores the role of artificial intelligence in diagnosing and treating inflammatory skin diseases. It discusses how AI and machine learning can improve precision medicine and clinical care. The paper outlines current applications and future potential of these technologies in dermatology.

How much of this paper we could read: full text read (0.80). We had a clear abstract, so the summary below closely tracks the paper. What this means →
2026

Abstract

The authors’ words, as The Journal of investigative dermatology supplied them

Recent advances in artificial intelligence (AI) and multimodal data collection are revolutionizing dermatology. Generative AI and machine-learning approaches offer opportunities to enhance the diagnosis and treatment of autoimmune and inflammatory skin diseases, including atopic dermatitis, psoriasis, hidradenitis suppurativa, vitiligo, alopecia areata, and rheumatic skin disease. This review examines the current landscape of AI applications for inflammatory skin diseases and explores how generative AI and machine-learning methods can advance the field through deep phenotyping, characterization of disease heterogeneity, drug discovery, precision medicine, and delivery of clinical care. We discuss the promises and challenges of these technologies and present a vision for their integration into clinical practice.

Background

The paper addresses the potential of artificial intelligence to transform the management of inflammatory skin diseases. With conditions like atopic dermatitis and psoriasis being complex and heterogeneous, AI offers tools for better diagnosis and personalized treatment. This study is significant as it reviews how AI can be integrated into dermatology to enhance patient outcomes.

Methods

This is a review article that synthesizes existing literature on AI applications in dermatology. It does not involve original experimental research but rather discusses various AI technologies and their potential uses in clinical settings.

Results

Not reported in abstract.

Interpretation

The review suggests that AI has the potential to significantly impact dermatology by improving diagnostic accuracy and enabling personalized treatment strategies. However, it also highlights challenges such as data privacy and the need for robust validation of AI tools. The lack of empirical data in the review limits the ability to assess the clinical impact of these technologies.

Key findings

  • AI and machine learning enhance diagnosis and treatment of autoimmune and inflammatory skin diseases.
  • Generative AI offers opportunities for deep phenotyping and disease heterogeneity characterization.
  • AI methods can aid in drug discovery and precision medicine.
  • The review discusses integration of AI technologies into clinical practice.

Limitations

  • review article, no new data
  • effectiveness of AI not empirically validated
  • potential bias in literature selection

Elsewhere in the ABS-201 corpus

CInsightful Backbone Modifications Preventing Proteolytic Degradation of Neurotensin Analogs Improve NT<i>S1</i>-Induced Protective Hypothermia.Frontiers in chemistry · 2020 · Sustained hypothermic effect of -3°C for at least 1 hour.In vitroCPharmacological hypothermia induced neurovascular protection after severe stroke of transient middle cerebral artery occlusion in mice.Experimental neurology · 2020 · Not reported in abstract.AnimalDTargeted temperature management and early neuro-prognostication after cardiac arrest.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2021reviewDSurface Functionalization of Nanocarriers with Anti-EGFR Ligands for Cancer Active Targeting.Nanomaterials (Basel, Switzerland) · 2025reviewCA peptide-neurotensin conjugate that crosses the blood-brain barrier induces pharmacological hypothermia associated with anticonvulsant, neuroprotective, and anti-inflammatory properties following status epilepticus in mice.eLife · 2025 · Not reported in abstract.AnimalDEmerging pharmacotherapies for androgenetic alopecia.Expert opinion on pharmacotherapy · 2026review